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Background: The mammal's inner ear is responsible for hearing and balance. To 
perform these tasks, it requires the vestibular and cochlear system. Sensor neural 
hearing loss (SNHL) is the most common type of hearing loss resulting in 
degeneration of internal sensory hair cell, where cochlear nerve in cochlear stem 
cell and gene-based strategies provide the opportunity for replacement for these 
cells. 
 
Aim: In this review, we evaluated the efficiency of stem cell therapy in inner ear. 
 
Methods: In this study we examined different articles in different databases such 
as Google Scholar, PubMed, and Elsevier. 
 
Results: The stem cells have offered desired results in the delivery of gene and 
tissue engineering programs. Evidence suggests that stem cells are considered as a 
promising tool in medical applications thanks to their high plasticity and trophic 
characteristics. 
 
Conclusion: In this review, Stem cell transplantation is widely used in clinical 
practice, and the source is highly desirable, since the patient's bone marrow cells 
can be potentially transplanted without any safety problems. 
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The mammals’ inner ear is responsible for 
hearing and balance, which occur through the 
vestibular and cochlear system. Auditory 
disturbances and the exposure to excessive 
noise, ototoxicity, aging and genetic mutations 
are associated with the damage or loss of 
various cell types in the inner ear. The 
common types of cells that are destroyed in 
these lesions include sensory hair cells, 
auditory and violet neurons, sterile 
vasculature, and fibrocytes in the spiral 
ligaments (1-7). In the mammals’ inner ear, if 
there is no replacement of internal progenitor 
cells, the permanent loss of sensory and 
neuronal cells is very limited, but in contrast, 
non-sensory cells such as fibrocytes in the 
spiral ligaments can be found after the damage 
caused by drug or noise (8, 9). Ischemia in the 
inner ear is associated with hearing 
impairment including sudden hearing loss, 
neurological sensitivity, presbycusis, hearing 
loss, tinnitus, and Meniere disease. In addition, 
the trauma also causes damage to the hair cells 
in the ear and to the labyrinth barrier blood in 
the Stria vascularis (10). Autoimmune inner 
ear disease (AIED) is an advanced, bilateral, 
and asymptomatic disease, in which the levels 
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of INFY produced by T cells are very high 
compared to normal people.(11). In this 
regard, Meniere disease is an autoimmune 
disease. It has been shown in 
immunohistological that beta-tubulin proteins 
accumulate in tremendous amounts in the 
inner ear tissue, such as hair cells, supportive 
cells, and spiral ganglion. In response to the 
accumulation of this protein, spatial 
distribution is altered in the ear, leading to the 
degeneration of the spiral ganglion. Some oral 
beta-tubulin treatments result in a reduction in 
INFY in response to beta-tubulin antigen, 
which is considered as a method for the 
treatment of EAHL (11). 
Sensorineural hearing loss (SNHL) is the most 
common type of hearing loss resulting in 
degeneration of internal sensory hair cells 
where cochlear nerves in the cochlear Stem 
cell and gene-based strategies provide the 
opportunity for replacement for these cells 
(12). The hair cells are produced only in the 
embryonic period and no hair cells are born 
after birth. The peripheral hearing process in 
the inner ear cochlear depends on two types of 
cells. 1: Spinal Ganglion neuron and hair cells 
(13). The acoustic waves cause mechanical 
stimulation in the hair cell, which leads to the 
release of neurotransmitters. Lack of hair cells 
will lead to deafness permanent (13). Hearing 
loss (SNHL) is a permanent sensory disorder 
that affects more than 270 million people 
worldwide (14). The prevalence of this disease 
in infants is 2 in 1,000; in children from 3 to 
17 years of age, 5 in 1,000; in people aged 65-
74, it is 33%, and in people over 85, it affects 
50% of the population (14). After hearing-
related age, noise-induced hearing loss (NIHL) 
is the second most common hearing which that 
can lead to preventable SNHL (15). In Europe, 
7% of workers are affected by hearing 
impairments and the consumption costs in this 
disease make up 10% of other occupational 
diseases. 
Among infants and children with SNHL, 23 to 
50 percent of SNHLs result from a genetic 
mutation (mutated canxin 26, Wardnerberg 
syndrome, arsenic syndrome, mitochondrial 
disorders, etc.). Other infants and children are 
affected by SNHL due to insufficiency, 
infection (in the uterus or after delivery), and 
exposure to noise or narcotics (14). In the 
mammals’ inner ear, if there is no substitution 
for the endogenous progenitor cells, the 
permanent loss of sensory and neuronal cells is 
very limited, but in contrast, non-sensory cells 
such as fibrocytes in the spiral ligament can 
damage themselves after the injury caused by 
drugs or noise (8, 9). It is estimated that the 
number of patients with neuronal hearing loss 
will double by 2030. The main current 
therapeutic option for SNHL patients is 
cochlear implantation. While these 
interventions are effective in many cases, 
some patients still struggle with physiological 
and psychosocial deafness. The cochlear 
implant transmits mechanical signals to 
electrical signals and delivers electric pulses to 
the auditory nerves to replace the function of 
the hair cells. However, these do not reproduce 
the sensory cells of the inner ear epithelium. 
The success of the cochlear nerve depends on 
the auditory nerves that send electrical signals 
to the auditory brain. Note that cochlear 
implantation for patients with auditory nerve 
disorders is limited (16). The function of a 
cochlear implant depends on the presence of 
the remaining spiral ganglion neurons, 
although the exact correlation between the 
number of ganglia and the result is not known. 
These observations indicate that the 
improvement of the spiral ganglion neuron can 
potentially enhance hearing in a number of 
people (17). 
Among other types of deafness, hearing 
neuropathy can be noted with the disease 
being associated with major damage to SGNs 
and relative intactness of hair cells (18). The 
auditory nerve damage in the ears of adult 
mammals is irreversible, leading to SNHL. 
The degenerative potential of the auditory 
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nerve has been tested in the mouse model of 
auditory nephropathy. Following the 
degeneration of the auditory nerve, glial cells 
are activated and the nucleus chromatin 
density decreases. The expression of histone 
deacetylase is altered while the expression of 
the neurogenesis gene is enhanced. The 
auditory nerve neurospheres are caused by 
neuronal damage or hypoxia conditions. The 
neurosphere formation assay shows that the 
neurons have progenitor cells. Glial cells in the 
auditory nerve exhibit different forms of 
progenitor cells that are very important in the 
auditory nerve repair (19). 
Corti's physical structure may be a barrier to 
stem cells where targeting stem cells in the 
sensory epithelium is an important challenge. 
Further, the fact that many of the trophic 
factors cause the stem cells to absorb the 
affected area is not supported in some studies. 
The activity of stem cells within the inner ear 
is an ideal source of epithelial-sensory 
regeneration of the ear. Although some studies 
have shown that the number of stem cells in 
mature Cochlear may have been somewhat 
low so far, many studies have been conducted 
on the use of stem-cell types in the inner ear 
with different results (17).  
In order to better understand the failure of 
epithelial regeneration and repair, a few 
therapeutic approaches to injury have been 
introduced. One of these methods is the 
transplantation of stem cells into the inner ear, 
where the transplanted cell is distinguished 
according to internal signals to the cells 
specific to that tissue. In the suspension culture 
of hearing epithelial cells, spherical cells have 
exhibited self-renewal features and genetic 
markers such as sox2, nestin, and nerve-
developing inner ear (20). The ultimate way to 
treat hearing loss is through applying 
genetically modified stem cells as a vector 
containing factors to enhance the regeneration 
of specific structures in the inner ear (17). 
Hair cells: 
The function of the hair cells depends on 
maintaining the electrochemical gradient 
between the endolymphatic and perilymphatic 
spaces. The boundary between these spaces is 
a tight junction between the luminal surface of 
the hair cells and the supporting cells. When a 
hair cell is destroyed, lamina reticula is 
disrupted causing defects. To prevent such a 
defect, the surrounding supporting cells 
expand their luminal surface by creating a 
fingertip, and closes the affected penetration 
like a dam. It seems likely that this scar can 
limit stem cell transplantation from access to 
the Corti organ which includes endolymph.  
Endolymph contains a high concentration of 
K+, which can be toxic to cells that are 
implanted in this chamber. The base levels of 
the supporting cells are on the basilar 
membrane, composed of various collagen 
forms. This membrane also seems to be a 
significant barrier to access of stem cell to 
Scala Tympani (17). In addition to the 
challenges mentioned above, it is also 
important to note that hair cells are not 
homogeneous in cochlear length and width. 
The longitudinal slope in cellular morphology 
corresponds to changes in the frequency 
regulation, while the internal and external hair 
follicle cells are located in the special position 
along the channel axis (internal to external). 
Finally, in order to improve the function, new 
hair cells should recognize synaptic 
functionalities with spiral ganglion neurons 
(17). 
 
Spinal ganglion neurons 
The spiral ganglion neurons have a unique 
bipolar morphology, and each neuron 
reconstructed requires not only the proper link 
with hair cells, but also proper communication 
with the auditory brain stem.  They grow in 
neurotrophins, such as BDNF and NT3, with 
these factors being released from stem cells 
that lead to increased growth. As the inner ear 
is filled with three parts of the fluid, the 
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secreted factors of the transplanted cells can 
potentially be spread across a specific 
chamber. Genetically engineered stem cells 
that release specific metabolic components can 
be used with endogenous stem cell 
transplantation to enhance regeneration in the 
inner ear. Another application of stem cells is 
in regeneration of spiral ganglion neurons. In 
humans, loss of spiral ganglion neurons is 
generally associated with hearing loss (21). 
There are reports of patients involving use of 
stem cells for regeneration of spiral ganglion 
cells (22). 
 
Types of cells used in treating the inner 
ear 
1) Human Pluripotent Stem Cell-derived 
Progenitor 
A study in 2018 showed that the first 
successful transplantation of exogenous cells 
was performed in prenatal rat otocysts. In this 
study, the otic progenitor cell from human IPS 
was successfully reported. The cells of the IPS 
were differentiated into the otic progenitor 
cells and then the progenitor of the otocyst 
cells as donation cells was used in mice (18).  
A study by Barboza and colleagues in 2016 
was performed to assay the auditory function 
in guinea pigs. Deafness was induced by 
neomycin. In this study, the inner ear 
progenitor cells were used. After 
transplantation, a number of these cells were 
observed at all points of the basal Scala in the 
damaged cochlea, which revealed the marker 
of myosin 7a hair cells, where some of them 
were found in the basilar coclide membrane. 
This study also showed the survival of cells in 
the corti’s organ after cochleostomy (20). 
In a study, multipotent cells were 
differentiated into committed progenitor cells 
initially in inner ear. Then, the committed 
progenitor cells were cultured on chicken 
utricle stromal cells and differentiated into 
hair-like cells. These cells have stereo cilia 
bundles (20).  
2) Bone marrow mesenchymal stem cells 
Bone marrow transplantation is widely used in 
clinical practice, and the source is highly 
desirable, since the patient's bone marrow cells 
can be potentially transplanted without any 
safety problems. Depending on the feasibility 
of many additional steps, such as surgical 
procedures for cellular transplantation to the 
damaged cochlea, it may be a treatment for 
hearing loss. Bone marrow mesenchymal stem 
cells also differentiate into different classes, 
including neurons, but the question is whether 
they can be differentiated into sensory cell 
lines (10). Bone marrow stem cells are a 
source of blood cells, but in addition to 
hematopoietic stem cells, there are 
mesenchymal stem cells that can be 
differentiated into the types of cells in the 
three layers of the fetus. In in-vivo studies, 
tracing stem cells transplanted into a specific 
tissue has been observed and found to 
differentiate into the same type of cell in the 
tissue (23, 24). Many of these cells have been 
used for transplantation and are a source of 
new cells for treatment (25). For regeneration 
of internal ear cells, the source for sensory 
cells and neurons is a valuable tool for clinical 
practice because neurons and hair cells can 
ultimately be used to treat patients with 
deafness. A recent study has shown that hair 
cells and neurons can differentiate from stem 
cells in the inner ear. Other studies have found 
that endogenous epithelial cells can be 
transformed into hair cells through the Math1 
transcription factor, while intraocular stem 
cells themselves cannot produce hair cells (9, 
26). Injection of the entire bone marrow to 
repair a mouse resulted in the absorption of 
these cells in areas occupied by the internal 
mesenchymal cells and fibrocytes, but did not 
produce hair cells (27).  
Through combining stimulation of growth 
factor and expression of the transcription 
factor (Math1), which is required for the 
formation of hair cell in inner ear, it has been 
shown that MSCs derived from bone marrow 
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can be differentiated into hair cells which 
expressed myosin VIIa genes, espin, jagged 2, 
Brn3c, p27Kip, representing a feature of the 
hair cells (28). Bone marrow mesenchymal 
stem cells isolated from guinea pigs, using 
recombinant lentivirus expressing IL4, can 
relieve the sensory nervous hearing loss 
caused by autoimmune disease. Bone marrow 
mesenchymal stem cells were implanted in 
Scala Tympani and Scala vestibule and 
reduced inflammatory injury by production of 
IL-4 (29). The source of mesenchymal cells 
and fibrocytes cells in the inner ear may be 
from bone marrow cells, and in particular from 
hematopoietic cells. In this study, bone 
marrow stem cells or colonies derived from 
hematopoietic stem cells were transmitted 
from transgenic mice expressing EGFP to 
adult mice (27). In a human pilot study, 
mesenchymal stem cells derived from bone 
marrow and their differentiation into hair cell 
and ganglionic cells were observed, but no 
significant improvement was observed in 
hearing. 
In the treatment of ischemia induced in the 
inner ear, different therapeutic methods have 
been used. One of these is use of vasoactive 
agents to improve the cochlear perfusion. For a 
damaged blood-labyrinth barrier, the iNOS 
was used with bone marrow stem cells. In this 
study, the first week following the injury, bone 
marrow stem cells GFP+were filtered into 
Blood-labyrinth barrier which accumulated 
more in two weeks post injury. iNOS improves 
the filtering of bone marrow stem cells. The 
cxcr4 and SDFa1 factors are essential for 
iNOS, and inhibition in the iNOS/SDFa1 
signaling pathway reduced damaged vessel 
regeneration. 
In a study, human bone marrow mesenchymal 
stem cells also differentiated into neurons 
which were transplanted to Scala tympani in a 
Guinea pig. Following the neuronal 
differentiation, a high level of neuronal 
markers and ion channel markers was 
expressed which is necessary for neuronal 
function. The number of the spiral ganglion 
cells also increased. These cells were found in 
pre lymphatic space, the corti’s organ, along 
the Cochlear neural fiber, spinal ganglion.  
The use of mesenchymal stem cells derived 
from bone marrow and its differentiation into 
the neuron in auditory neuropathy revealed 
that the number of spinal ganglion cells also 
increased. The results of this study suggested 
that there is a possibility of replacing 
degenerated spiral ganglion cells with 
transplantation of stem cell in Scala Tympani. 
3) Stem cells derived from umbilical Cord 
The human embryonic mesenchymal stem 
cells are believed to be multipotent stem cells 
and have shown desired results in the delivery 
of gene and tissue engineering programs. 
UCMSCs are isolated from the Wharton’s jelly 
of umbilical cord and have some common 
properties with bone marrow mesenchymal 
stem cells (BMSCs) .(30). Umbilical cord is a 
rich source of cells. This can be due to the 
high frequency of umbilical cord and low 
immune rejection and non-tumor properties as 
a suitable source for cellular transplantation in 
medicine. These cells differentiate into several 
types of cells and have a potential potency in 
the gene delivery. Mesenchymal cells derived 
from Wharton jelly can also differentiate into 
different types of cells in three embryonic 
layers.  
In vitro, the differentiation of these cells has 
been observed into osteocyte cells, 
hepatocytes, chondrocytes, adipocytes and 
neural cells, pancreatic cell (19-22). The 
Atoh1 gene is expressed in the internal hair 
cell of the ear and nerve cells in the hindbrain, 
spinal cord and germinal layer of the 
cerebellum (23). The Atoh1 gene in the 
mesenchymal cells produced by umbilical cord 
causes the cells to differentiate into cells 
similar to those of the hair cells in the inner 
ear. Also, mesenchymal cells derived from 
human umbilical cord in the subarachnoid 
space have been injected into congenital 
Albian pigs, resulting in the appearance of 
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these cells in three days and four weeks post 
injection. Further, the cells in this study were 
evaluated at 2 hours, 3 days and 1, 2, 3, 4 
weeks after the transplantation in the cochlea. 
These cells also migrated from the 
subarachnoid space to the inner ear, the central 
nervous system and environmental organs. 
Indeed, mesenchymal cells were able to 
migrate from the CSF to the inner ear, as the 
presence of these cells in the cochlea may be 
due to changes in ABR waveforms (24). The 
use of umbilical cord blood cells in children 
aged 6 months to 6 years in the clinical trial 
phase 1 showed no side effects. No toxicity 
related to injection has been recorded. 
Improvement in the cochlear nerve and ABR 
reduction was also observed (25).  
4) Embryonic stem cells 
Human embryonic stem cells are pluripotent 
stem cells that differentiate into all types of 
cells that are present in the human body. One 
of these cells is hair cells (26). Also in vitro, 
embryonic stem cells were differentiated into 
hair cells in stromal cells condition media 
(ST2-CM) and injected into chick embryos. In 
addition, EB (embryonic body) cells in stromal 
culture media expressed hair cell markers, 
including Brn3c Math1, myosin6, myosin7a, 
calretinin, and a9AchR, and formed structures 
similar to stereo cilia (27). Also, embryonic 
body cells were transfected with math1 and 
differentiated into hair like cells, and 
expressed the markers of hair cells, and also 
produced stereo cilia (28). Note that MIF-
induced embryonic stem cells can replace lost 
or damaged SGNs (spiral ganglion cells). 
Neuronal cells and Schwann cells were 
generated from a population of embryonic 
stem cells in an ultra-slow flow microfluidics 
device. In this study, neurons were grown on a 
population of Schwann cells and their primary 
myelination was reported. Spinal ganglion 
cells are mild in the bipolar neurons that 
receive sensory signals from peripheral 
sensory receptors in the hair cells and transfer 
them to the central neurons in the auditory 
cores in the brain stem (29). Essentially, stem 
cells must be directed to the cochlea replacing 
damaged hair cells, where the survival of these 
cells and their integration with tissue is 
essential. Following the transfer of cells to 
Scala Timpani, these cells do not reach the 
auditory epithelium. The auditory epithelium 
is extremely effective for transmitting sound, 
where most of the cells in the transplant in 
Scala Media are lost due to the high 
concentrations of K+. Flushing Scales Medium 
with sodium increases survival before 
embryonic stem cell transplantation. In this 
study, in addition to increased survival in 
embryonic stem cells, differentiation into hair 
cells was observed (26). 
Direct differentiation of embryonic stem cells 
into bipolar neurons can replace them for 
degenerated neurons in damaged cochlea. This 
also facilitates the differentiation of embryonic 
stem cells into neuron-like cells 
simultaneously with co-culture of neurons or 
hair cells that are isolated from postnatal day 
five rats. This results in an increase in 
neuronal-like cells and a rise in the number of 
neurofilaments. 
5) Adipose derived stem cells 
Evidence suggests that adipose-derived stem 
cells are considered as a promising means in 
medical applications due to their high 
plasticity and trophic characteristics. In this 
regard, transfusion of fetal stem cells in the 
acoustic trauma model in guinea pig increases 
the expression in the chemokine ligand and 
receptors associated with PDGF, VEGF, and 
TGFB which are effective in migration of 
mesenchymal stem cells. Adipose-derived 
stem cells can migrate to damaged tissue and 
express trophic factors. Adipose mesenchymal 
stem cells could also suppress T cells and 
inducing Treg cells in the model of 
autoimmune hearing loss in mice. In this 
study, was observed a reduction in 
proliferation of TH1/TH2 cells, increased anti-
inflammatory cytokines such as IL10 and the 
production of CD4+CD25+FOXP3+cells (15). 
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6) Other cells 
Neural stem cell line 
The use of neural stem cell line causes a 
significant increase in satellite cells and spiral 
ganglion cells of type I. These cells migrate 
from Scala tympani to Rosenthal's canal 
channel and the Corti’s organs (19). 
The Cochlear support cells express Lgr5 +. 
Lgr5 + is an epithelial marker which responds 
to stimuli of the wnt signaling pathway and the 
Gsk3B inhibitor. In this study, Lgr5 + 
supporting cells were isolated with the aim of 
replacing damaged cochlear hair cells which 
were differentiated into hair cells by growth 
factor and drug (19). 
 
Acknowledgements 
This work was supported by Hearing 
Disorders Research Center of Shahid Beheshti 
University of Medical Sciences.  
The authors would like to thank the Clinical 
Research Development Unit (CRDU) of 
Loghman Hakim Hospital, Shahid Beheshti 
University of Medical Sciences (Tehran, Iran) 
for their cooperation and assistance throughout 
the period of study. 
 
Conflicts of Interest 











1. Farkashidy J, Black RG, Briant TDR. The effect 
of kanamycin on the internal ear: an 
electrophysiological and electron microscopic 
study. The Laryngoscope. 1963;73(6):713-27. 
2. Liberman MC, Kiang NY. Acoustic trauma in 
cats: cochlear pathology and auditory-nerve 
activity. Acta oto-laryngologica. 1978. 
3. Steel KP, Bock GR. The nature of inherited 
deafness in deafness mice. Nature. 1980 
Nov;288(5787):159. 
4. Schuknecht HF, Gacek MR. Cochlear pathology 
in presbycusis. Annals of Otology, Rhinology & 
Laryngology. 1993 Jan;102(1_suppl):1-6. 
5. Spicer SS, Schulte BA. Spiral ligament 
pathology in quiet-aged gerbils. Hearing research. 
2002 Oct 1;172(1-2):172-85. 
6. Kusunoki T, Cureoglu S, Schachern PA, Baba K, 
Kariya S, Paparella MM. Age-related 
histopathologic changes in the human cochlea: a 
temporal bone study. Otolaryngology—Head and 
Neck Surgery. 2004 Dec;131(6):897-903. 
7. Ohlemiller KK. Age-related hearing loss: the 
status of Schuknecht’s typology. Current opinion in 
otolaryngology & head and neck surgery. 2004 Oct 
1;12(5):439-43. 
8. Hirose K, Liberman MC. Lateral wall 
histopathology and endocochlear potential in the 
noise-damaged mouse cochlea. Journal of the 
Association for Research in Otolaryngology. 2003 
Sep 1;4(3):339-52. 
9. Zheng JL, Gao WQ. Overexpression of Math1 
induces robust production of extra hair cells in 
postnatal rat inner ears. Nat Neurosci. 2000 
Jun;3(6):580. 
10. Dai M, Yang Y, Omelchenko I, Nuttall AL, 
Kachelmeier A, Xiu R, Shi X. Bone marrow cell 
recruitment mediated by inducible nitric oxide 
synthase/stromal cell-derived factor-1α signaling 
repairs the acoustically damaged cochlear blood-
labyrinth barrier. The American journal of 
pathology. 2010 Dec 1;177(6):3089-99. 
11. Zhou Y, Yuan J, Zhou B, Lee AJ, Lee AJ, 
Ghawji Jr M, Yoo TJ. The therapeutic efficacy of 
human adipose tissue‐derived mesenchymal stem 
cells on experimental autoimmune hearing loss in 
mice. Immunology. 2011 May;133(1):133-40. 
12. Abbaszadeh HA, Tiraihi T, Sadeghi Y, Delshad 
AR, Sadeghizadeh M, Taheri T, Noori-Zadeh A. 
Decrease in cavity size and oligodendrocyte cell 
death using neurosphere-derived oligodendrocyte-
like cells in spinal cord contusion model. Iranian 
biomedical journal. 2018 Jul;22(4):246. 
13. Koehler KR, Mikosz AM, Molosh AI, Patel D, 
Hashino E. Generation of inner ear sensory 
REVIEW ARTICLE 
Journal of Otorhinolaryngology and Facial Plastic Surgery. 2019; 5(1):1-8. 
DOI: https://doi.org/10.22037/ORLFPS.v5i1.27283 
------------------------------------------------------------------------------------------------------------------ 
This work is distributed under the terms of the Creative Commons Attribution Non Commercial 4.0 License 
 (CC BY-NC 4.0). 
8 
epithelia from pluripotent stem cells in 3D culture. 
Nature. 2013 Aug;500(7461):217. 
14. Baumgartner LS, Moore E, Shook D, Messina 
S, Day MC, Green J, Nandy R, Seidman M, 
Baumgartner JE. Safety of Autologous Umbilical 
Cord Blood Therapy for Acquired Sensorineural 
Hearing Loss in Children. Journal of audiology & 
otology. 2018 Oct;22(4):209. 
15. Darabi S, Tiraihi T, Noori-Zadeh A, Rajaei F, 
Darabi L, Abbaszadeh H. Creatine and retinoic acid 
effects on the induction of autophagy and 
differentiation of adipose tissue-derived stem cells 
into GABAergic-like neurons. Journal of Babol 
university of medical sciences. 2017 Aug 
15;19(8):41-9. 
16. Ma Y, Guo W, Yi H, Ren L, Zhao L, Zhang Y, 
Yuan S, Liu R, Xu L, Cong T, EK O. 
Transplantation of human umbilical cord 
mesenchymal stem cells in cochlea to repair 
sensorineural hearing. American journal of 
translational research. 2016;8(12):5235. 
17. Sefati N, Abbaszadeh HA, Fadaei Fathabady F, 
et al. The combined effects of mesenchymal stem 
cell conditioned media and low-level laser on 
stereological and biomechanical parameter in 
hypothyroidism rat model. J Lasers Med Sci. 
2018;9(4):243-248. 
18. Chen W, Jongkamonwiwat N, Abbas L, Eshtan 
SJ, Johnson SL, Kuhn S, Milo M, Thurlow JK, 
Andrews PW, Marcotti W, Moore HD. Restoration 
of auditory evoked responses by human ES-cell-
derived otic progenitors. Nature. 2012 
Oct;490(7419):278. 
19. Lang H, Xing Y, Brown LN, Samuvel DJ, 
Panganiban CH, Havens LT, Balasubramanian S, 
Wegner M, Krug EL, Barth JL. Neural 
stem/progenitor cell properties of glial cells in the 
adult mouse auditory nerve. Sci Rep. 2015 Aug 
26;5:13383. 
20. Barboza Jr LC, Lezirovitz K, Zanatta DB, 
Strauss BE, Mingroni-Netto RC, Oiticica J, Haddad 
LA, Bento RF. Transplantation and survival of 
mouse inner ear progenitor/stem cells in the organ 
of Corti after cochleostomy of hearing-impaired 
guinea pigs: preliminary results. Brazilian J Med 
Biol Res. 2016;49(4). 
21. Zimmermann CE, Burgess BJ, Nadol Jr JB. 
Patterns of degeneration in the human cochlear 
nerve. Hear Res. 1995 Oct 1;90(1-2):192-201. 
22. Linthicum Jr FH, Fayad J. Spiral ganglion cell 
loss is unrelated to segmental cochlear sensory 
system degeneration in humans. Otology & 
neurotology: official publication of the American 
Otological Society, American Neurotology Society 
[and] European Academy of Otology and 
Neurotology. 2009 Apr;30(3):418. 
23. Mezey É, Key S, Vogelsang G, Szalayova I, 
Lange GD, Crain B. Transplanted bone marrow 
generates new neurons in human brains. 
Proceedings of the National Academy of Sciences. 
2003 Feb 4;100(3):1364-9. 
24. Weimann JM, Charlton CA, Brazelton TR, 
Hackman RC, Blau HM. Contribution of 
transplanted bone marrow cells to Purkinje neurons 
in human adult brains. Proceedings of the National 
Academy of Sciences. 2003 Feb 18;100(4):2088-
93. 
25. Satoh T, Fekete DM. Clonal analysis of the 
relationships between mechanosensory cells and 
the neurons that innervate them in the chicken ear. 
Development. 2005 Apr 1;132(7):1687-97. 
26. Izumikawa M, Minoda R, Kawamoto K, 
Abrashkin KA, Swiderski DL, Dolan DF, Brough 
DE, Raphael Y. Auditory hair cell replacement and 
hearing improvement by Atoh1 gene therapy in 
deaf mammals. Nature medicine. 2005 
Mar;11(3):271. 
27. Niknazar S, Nahavandi A, Peyvandi AA, 
Peyvandi H, Roozbahany NA, Abbaszadeh HA. 
Hippocampal NR3C1 DNA methylation can 
mediate part of preconception paternal stress 
effects in rat offspring. Behavioural brain research. 
2017 May 1;324:71-6. 
28. Jeon SJ, Oshima K, Heller S, Edge AS. Bone 
marrow mesenchymal stem cells are progenitors in 
vitro for inner ear hair cells. Molecular and Cellular 
Neuroscience. 2007 Jan 1;34(1):59-68. 
29. Mohsenifar Z, Fridoni M, Ghatrehsamani M, 
Abdollahifar MA, Abbaszadeh H, Mostafavinia A, 
Fallahnezhad S, Asghari M, Bayat S, Bayat M. 
Evaluation of the effects of pulsed wave LLLT on 
tibial diaphysis in two rat models of experimental 
osteoporosis, as examined by stereological and 
real-time PCR gene expression analyses. Lasers 
Med Sci. 2016 May 1;31(4):721-32. 
30. Weiss ML, Medicetty S, Bledsoe AR, 
Rachakatla RS, Choi M, Merchav S, Luo Y, Rao 
MS, Velagaleti G, Troyer D. Human umbilical cord 
matrix stem cells: preliminary characterization and 
effect of transplantation in a rodent model of 
Parkinson's disease. Stem cells. 2006 
Mar;24(3):781-92. 
 
